Submit Your Late-Breaking, Encore, or Trials in Progress Abstract
There’s still time to have your research considered for presentation at the ASCPT 2024 Annual Meeting. Submit your Late-Breaking, Encore, or Trials in Progress abstract by November 9, 2024.
Join your fellow clinical pharmacologists and translational scientists in Colorado Springs, CO, March 27-29, 2024, and present your research inside a dedicated poster hall. If you have data that could not be finalized before September 14, 2023, due to unavailability of data, submit it as a Late-Breaking abstract. If you have significant, ground-breaking, and innovative findings that were published as an original research article in a peer-reviewed journal on or after January 1, 2023, and that address a question of relevance to clinical pharmacology and therapeutics, submit as an Encore abstract. If you have an ongoing clinical trial, we encourage you to submit within the Trials in Progress category.
Trials in Progress are designated for abstracts that describe something novel within the application areas of ASCPT, providing “coming attractions” for clinical pharmacologists and translational scientists in practice. Abstracts submitted as Trials in Progress should be ongoing without reportable results at the submission deadline. As such, Trials in Progress should not include results.
Review full criteria
for all abstract submission categories and submit by November 9, 2023, 4:00 PM ET
. Questions about criteria or submission can be sent to firstname.lastname@example.org